期刊文献+

肝动脉化疗栓塞术后胆管损伤的影像学研究 被引量:13

Investigation of bile duct injury after transcatheter arterial chemoembolization
原文传递
导出
摘要 目的观察经导管肝动脉化疗栓塞术(TACE)治疗肝脏恶性肿瘤后继发胆管损伤的影像学表现.方法 1240例患者行TACE 2680次,18例于TACE术后3周~3个月出现胆管损伤.18例TACE前后均行CT和超声波检查,14例行MRI,15例行血管造影.对18例不同类型的肝脏恶性肿瘤TACE术后胆管损伤的发生率、影像学表现及导致胆管损伤的高危因素进行回顾性分析.结果肝转移性肿瘤TACE术后胆管损伤的发生率为8.8%(13/148),肝细胞性肝癌(HCC)胆管损伤的发生率为0.5%(5/1092).影像学表现为局灶性胆管扩张4例,多灶性肝段-亚段胆管扩张8例,巨大囊性病灶或胆汁瘤6例.胆管损伤区肝叶-段呈进行性萎缩6例.分析结果显示,TACE术后胆管损伤多发生于无肝硬变者的肝转移瘤患者(P<0.01);同时,使用铂类制剂与碘油乳化行TACE以及肿瘤为少血供型(P均<0.01),也是高危因素.结论 TACE后可出现局灶性、多灶性胆管扩张和胆汁瘤等胆管损伤表现;无肝硬变者是TACE后造成胆管损伤的主要危险因素. Objective To investigate the image findings of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Methods During the past 3 years, 1240 patients with different hepatic malignancies had undergone a total of 2680 TACE procedures. Eighteen patients (1.4%)developed bile duct injuries from 3 weeks to 3 months after TACE. All of the 18 patients received follow-up CT and uhra-sonography, 14 MRI and 15 digital subtract angiography (DSA). The image data was retrospectively reviewed, with the potential predisposing factors correlated to TACE-induced bile duct injury. Results TACE-induced bile duct injuries developed in 13 of 148 patients with liver metastasis (8.8%), 5 of 1092 patients with hepatocellular carcinoma (HCC) (0.5%). On image examination, focal peripheral intrahepatic bile duct dilatation was detected in 4 cases, multiple bile duct dilatations with segmental or sub-segmental distribution in 8, and a large lobular cystic lesion or biloma in 6 cases, and progressive atrophy of the corresponding hepatic parenchyma in 6 patients in whom the TACE induced-bile injury developed at different intervals after TACE. The incidence of bile duct injury was higher in noncirrhotic patients with metastatic liver lesions than in patients with hepatocellular carcinoma associated with cirrhosis ( P 〈0.01 ), and it was also higher in patients using an emulsion of lipiodol-cisplatin or carboplatin than in patients using other emboliging agents (P 〈0.01 ). The incidence was higher either in patients with hypovascular lesions than in patients with hypervascular lesions ( P 〈 0. 05 ). Conclusion Biliary abnormalities, including focal and multiple intrahepatic bile duct dilatation, and cystic lesion or biloma, may develop and can be detected during the follow-up examination imaging in patients with hepatic malignancy after TACE. Noncirrhotic liver and intact function, due to the lack of peri-biliany collateral circulation, are the significant predispos
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2005年第10期609-612,共4页 Chinese Journal of Oncology
关键词 肝动脉化疗栓塞术 肝肿瘤 胆管损伤 影像学 Transcatheter arterial chemoembolization Liver neoplasms Bile duct injury Imaging investigation
  • 相关文献

参考文献8

  • 1Barone M, Ettorre GC, Ladisa R, et al. Transcatheter arterial chemoembolization ( TACE ) in treatment of hepatocellular carcinoma. Hepatogastroenterology ,2003,50 : 183-718. 被引量:1
  • 2程红岩,徐爱民,陈栋,贾雨辰.根据大肝癌的血供特点确定介入治疗的碘油剂量[J].中华肿瘤杂志,2003,25(2):186-189. 被引量:25
  • 3钱骏,冯敢生.原发性肝癌的综合介入治疗[J].中华肿瘤杂志,2003,25(5):417-419. 被引量:40
  • 4Yu JS, Kim KW, Jeong MG, et al. Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol, 2002, 25:270-274. 被引量:1
  • 5Tarazov PG, Polysalov VN, Prozorovskij KV, et al. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies. Acta Radiol, 2000,41:156-160. 被引量:1
  • 6Kim HK, Chung YH, Song BC, et al. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenteml, 2001, 32:423-427. 被引量:1
  • 7Yu JS, Kim KW, Park MS, et al. Bile duct injuries leading to portal vein obliteration after transcatheter arterial chemoembolization in the liver: CT findings and initial observations. Radiology, 2001, 221:429-436. 被引量:1
  • 8Kim W, Clark TW, Baum RA, et al. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol,2001, 12:965-968. 被引量:1

二级参考文献21

  • 1冯敢生.中药白芨作为血管栓塞剂的动物实验研究和临床应用[J].中华放射学杂志,1985,4:193-197. 被引量:5
  • 2于志坚 孟宪镛.HCPT、CDDP、5-FU等肝动脉栓塞灌注治疗原发性肝癌86例[J].中华放射学杂志,2000,34:666-669. 被引量:2
  • 3Gerolami R, Cardoso J, Lewin M, et al. Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratmnoral and intrahepatic artery routes. Cancer Res, 2000, 60: 993-1001. 被引量:1
  • 4Seol JG, Heo DS, Kim HK, et al. Selective gene expression in hepatic tumor with trans-arterial delivery of DNA/liposome/tranferrin complex.In Vivo, 2000, 14: 513-517. 被引量:1
  • 5Drozdzik M, Qian C, Xie X, et al. Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma. J Hepatol, 2000, 32:279-286. 被引量:1
  • 6Rak JW, St Croix DB, Kerbel RS. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anti Cancer Drugs,1995, 6: 3-18. 被引量:1
  • 7Augustin HG. Antiangiogenic tumor therapy: will it work? Trends Pharmacol Sci. 1998. 19: 216-222. 被引量:1
  • 8O'reilly MS, Boehm T, Siting Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997, 88: 277-285. 被引量:1
  • 9Black WR, Agner RC. Tumour regression after endostatin therapy. Nature, 1998, 391: 450. 被引量:1
  • 10Koyama H, Nishizawa Y, Hosoi M, et al. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-Ⅰ : possible involvement of cyclin-dependent kinase 2. Cirr Res, 1996, 79: 757-764. 被引量:1

共引文献63

同被引文献86

引证文献13

二级引证文献217

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部